A Homozygous Variant in HSD17B1 Identified in Women With Poor Ovarian Response

被引:0
|
作者
Ren, Jingyi [1 ]
Ouyang, Yan [1 ,2 ]
Wang, Shuangyao [1 ]
Gong, Fei [1 ,2 ]
Lu, Guangxiu [1 ,2 ]
Lin, Ge [1 ,2 ]
Guo, Jing [1 ,2 ]
机构
[1] Cent South Univ, Sch Basic Med Sci, NHC Key Lab Human Stem Cell & Reprod Engn, Changsha, Peoples R China
[2] Reprod & Genet Hosp CITIC Xiangya, Clin Res Ctr Reprod & Genet Hunan Prov, Changsha, Peoples R China
关键词
female infertility; follicle development; POR; HSD17B1;
D O I
10.1111/cge.14707
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
An increasing number of patients utilizing in vitro fertilization (IVF) and assisted reproductive technology (ART) are characterized as impaired or poor ovarian responders (PORs). Owing to its unclear molecular etiology, the management of patients with age-related ovarian characteristics remains a controversial and complex clinical concern. Therefore, it is important to identify and understand the etiological causes behind POR to develop more effective and efficient management strategies for these patients. In this study, we report a homozygous HSD17B1 (accession number: NM_000413.4) variant (c.718-1G>C) in a patient with POR from a consanguineous family. The proband, a 33-years-old woman, exhibited poor ovarian reserve prestimulation parameters (antral follicle count < 5; anti-M & uuml;llerian hormone = 0.386 ng/mL), resulting in the classification of this patient as patient oriented strategies encompassing individualized oocyte number (POSEIDON) group three according to the POSEIDON criteria. Additionally, this patient displayed impaired estradiol production and reduced 17-ketosteroids secretion and multiple ovarian cysts, which differed from previously reported POR cases. Overall, our findings provide valuable insights for researchers and clinicians into the relationships between the phenotype and genotype of POR and the HSD17B1 gene.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk
    Sainz, J.
    Rudolph, A.
    Hein, R.
    Hoffmeister, M.
    Buch, S.
    von Schoenfels, W.
    Hampe, J.
    Schafmayer, C.
    Voelzke, H.
    Frank, B.
    Brenner, H.
    Foersti, A.
    Hemminki, K.
    Chang-Claude, J.
    ENDOCRINE-RELATED CANCER, 2011, 18 (02) : 265 - 276
  • [42] Macronutrient intakes and serum oestrogen, and interaction with polymorphisms in CYP19A1 and HSD17B1 genes: a cross-sectional study in postmenopausal Japanese women
    Takagi, Sahoko
    Naito, Mariko
    Kawai, Sayo
    Okada, Rieko
    Nagata, Chisato
    Hosono, Satoyo
    Nishida, Yuichiro
    Takashima, Naoyuki
    Suzuki, Sadao
    Shimoshikiryo, Ippei
    Mikami, Haruo
    Uemura, Hirokazu
    Kuriyama, Nagato
    Ohnaka, Keizo
    Kubo, Michiaki
    Hamajima, Nobuyuki
    Tanaka, Hideo
    Wakai, Kenji
    BRITISH JOURNAL OF NUTRITION, 2017, 118 (06) : 463 - 472
  • [43] Deleting the mouse Hsd17b1 gene results in a hypomorphic Naglu allele and a phenotype mimicking a lysosomal storage disease
    Heli Jokela
    Janne Hakkarainen
    Laura Kätkänaho
    Pirjo Pakarinen
    Suvi T. Ruohonen
    Manuel Tena-Sempere
    Fu-Ping Zhang
    Matti Poutanen
    Scientific Reports, 7
  • [44] Deleting the mouse Hsd17b1 gene results in a hypomorphic Naglu allele and a phenotype mimicking a lysosomal storage disease
    Jokela, Heli
    Hakkarainen, Janne
    Katkanaho, Laura
    Pakarinen, Pirjo
    Ruohonen, Suvi T.
    Tena-Sempere, Manuel
    Zhang, Fu-Ping
    Poutanen, Matti
    SCIENTIFIC REPORTS, 2017, 7
  • [45] Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19
    Tsuchiya, M
    Nakao, H
    Katoh, T
    Sasaki, H
    Hiroshima, M
    Tanaka, T
    Matsunaga, T
    Hanaoka, T
    Tsugane, S
    Ikenoue, T
    HUMAN REPRODUCTION, 2005, 20 (04) : 974 - 978
  • [46] Polymorphism of HSD17B1 Ser312Gly with Cancer Risk: Evidence from 66,147 Subjects
    Shi, Lijun
    Yang, Xue
    Dong, Xin
    Zhang, Botao
    TWIN RESEARCH AND HUMAN GENETICS, 2016, 19 (02) : 136 - 145
  • [47] An HSD17B13 variant reduces cirrhosis risk
    Hugh Thomas
    Nature Reviews Gastroenterology & Hepatology, 2018, 15 : 328 - 328
  • [48] An HSD17B13 variant reduces cirrhosis risk
    Thomas, Hugh
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (06) : 328 - 328
  • [49] Dioxin exposure reduces the steroidogenic capacity of mouse antral follicles mainly at the level of HSD17B1 without altering atresia
    Karman, Bethany N.
    Basavarajappa, Mallikarjuna S.
    Hannon, Patrick
    Flaws, Jodi A.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 264 (01) : 1 - 12
  • [50] Haplotype analysis of the HSD17B1 gene and risk of breast cancer:: A comprehensive approach to multicenter analyses of prospective cohort studies
    Feigelson, HS
    Cox, DG
    Cann, HM
    Wacholder, S
    Kaaks, R
    Henderson, BE
    Albanes, D
    Altshuler, D
    Berglund, G
    Berrino, F
    Bingham, S
    Buring, JE
    Burtt, NP
    Calle, EE
    Chanock, SJ
    Clavel-Chapelon, F
    Colditz, G
    Diver, WR
    Freedman, ML
    Haiman, CA
    Hankinson, SE
    Hayes, RB
    Hirschhorn, JN
    Hunter, D
    Kolonel, LN
    Kraft, P
    LeMarchand, L
    Linseisen, J
    Modi, W
    Navarro, C
    Peeters, PH
    Pike, MC
    Riboli, E
    Setiawan, VW
    Stram, DO
    Thomas, G
    Thun, MJ
    Tjonneland, A
    Trichopoulos, D
    CANCER RESEARCH, 2006, 66 (04) : 2468 - 2475